MEIRAGTX HOLDINGS

Summary

MeiraGTx is a vertically integrated, clinical-stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 25 M

Avg. Deal Size£ 25 M

Market Context

Senior Management

Alexandria Forbes
President CEO
Richard Giroux
CFO

Sort

30 Oct 2023|United States|Biotechnology

Target: MEIRAGTX HOLDINGS

Bidder: SANOFI SA

5 Service Providers

4 Target | 1 Bidder

14 Dealmakers

12 Target | 2 Bidder

£ 24 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy